Azapoğlu Kaymak Burcu, Eksioglu Merve, Cimilli Öztürk Tuba, Köroğlu Mehmet
University of Health Sciences, Fatih Sultan Mehmet Education and Research Hospital, Department of Emergency Medicine, Istanbul, Turkey.
University of Health Sciences, Fatih Sultan Mehmet Education and Research Hospital, Department of Gastroenterology, Istanbul, Turkey.
Int J Gen Med. 2025 May 5;18:2391-2400. doi: 10.2147/IJGM.S520925. eCollection 2025.
Upper gastrointestinal bleeding (UGIB) poses significant risks of morbidity and mortality, necessitating effective risk stratification tools. Traditional scoring systems such as the Rockall (RS), Glasgow-Blatchford (GBS), and AIMS65 have limitations in accurately predicting mortality and rebleeding. The Hemoglobin, Albumin, Lymphocyte, Platelet (HALP) score, initially developed for cancer prognosis, has demonstrated prognostic value in various conditions. This study aims to evaluate whether the HALP score, when assessed at admission, aligns with the Rockall score and can be used to predict rebleeding and 30- day mortality in UGIB patients.
This retrospective study included 256 patients with confirmed UGIB admitted to a tertiary hospital in Istanbul, Turkey, between 2017 and 2024. Patient data, including demographics, vital signs, laboratory parameters, endoscopic findings, and clinical outcomes, were collected. The HALP score was calculated at admission to the emergency department. ROC curve analysis assessed the predictive accuracy of the HALP score for 30-day mortality, rebleeding, and its performance was compared with the Rockall score.
The predictive performance of the HALP and Rockall scores for 30-day mortality and rebleeding was evaluated using ROC analysis, with AUC values of 0.772 (95% CI: 0.715-0.822) and 0.770 (95% CI: 0.714-0.820) for mortality prediction, respectively ( = 0.9801). For rebleeding prediction, the Rockall score had a higher AUC (0.739, 95% CI: 0.681-0.792) than the HALP score (0.688, 95% CI: 0.627-0.744), though the difference was not statistically significant ( = 0.2969).
The results of this study demonstrate that the HALP score can be used for prognosis prediction in UGIB, exhibiting comparable sensitivity and specificity to the Rockall score. Its ease of calculation using routine laboratory parameters offers a practical complement to existing scoring systems.
上消化道出血(UGIB)会带来显著的发病和死亡风险,因此需要有效的风险分层工具。传统的评分系统,如罗卡尔(RS)、格拉斯哥 - 布拉奇福德(GBS)和AIMS65,在准确预测死亡率和再出血方面存在局限性。血红蛋白、白蛋白、淋巴细胞、血小板(HALP)评分最初是为癌症预后而开发的,已在多种情况下显示出预后价值。本研究旨在评估入院时评估的HALP评分是否与罗卡尔评分一致,以及是否可用于预测UGIB患者的再出血和30天死亡率。
这项回顾性研究纳入了2017年至2024年间在土耳其伊斯坦布尔一家三级医院确诊为UGIB的256例患者。收集了患者的数据,包括人口统计学、生命体征、实验室参数、内镜检查结果和临床结局。在急诊科入院时计算HALP评分。通过ROC曲线分析评估HALP评分对30天死亡率、再出血的预测准确性,并将其性能与罗卡尔评分进行比较。
使用ROC分析评估HALP和罗卡尔评分对30天死亡率和再出血的预测性能,死亡率预测的AUC值分别为0.772(95%CI:0.715 - 0.822)和0.770(95%CI:0.714 - 0.820)(P = 0.9801)。对于再出血预测,罗卡尔评分的AUC(0.739,95%CI:0.681 - 0.792)高于HALP评分(0.688,95%CI:0.627 - 0.744),尽管差异无统计学意义(P = 0.2969)。
本研究结果表明,HALP评分可用于UGIB的预后预测,其敏感性和特异性与罗卡尔评分相当。使用常规实验室参数进行计算的简便性为现有评分系统提供了实用的补充。